Measuring eye changes to detect dementia
Official title: Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
Run by MD Stem Cells · NCT06613971 · Data updated 2026-11-12
This study is testing a new eye exam to see if it can help tell the difference between people with and without dementia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | MD Stem Cells Industry-sponsored |
| Locations | 1 site (Coconut Creek, Florida) |
| Status | Recruiting |
| Started | April 25, 2024 |
| Main results expected | April 25, 2027 |
| Study ends | April 25, 2028 |
| Registry record updated | May 8, 2025 |
| Trial ID | NCT06613971 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals capable of undergoing an ophthalmic evaluation and providing informed consent.
✕Probably not a fit
Patients who are not medically stable or at significant health risk may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the utility of dynamic light scattering spectroscopy, a noninvasive technique, in differentiating between patients with and without dementia by measuring changes in the eye. The research focuses on identifying which types of dementia can be detected and at what stages using this method. Participants will undergo an ophthalmic evaluation to ensure they can cooperate with the testing process. The study seeks to provide a new diagnostic tool for dementia, which is currently challenging to diagnose definitively until posthumously.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accurate diagnoses of dementia, improving patient management and care.
How similar studies have gone: While the approach of using eye measurements for dementia detection is innovative, similar studies have shown promise in exploring noninvasive diagnostic techniques for neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. All patients must be capable of an adequate ophthalmic evaluation and testing. This includes the ability to cooperate with the exam, sufficiently clear media (cornea, lens, vitreous) and sufficient pupillary dilation. 2. Patients must be capable of providing informed consent. 3. Patients who are not medically stable or who may be at significant risk to their health will not be eligible. 4. Women of child bearing age must not be pregnant at the time of examination.
Where it's running
-
3T Radiology
Coconut Creek, Florida, United States Recruiting
Study contacts
- Principal investigator: Jeffrey N Weiss, MD — The Healing Institute
- Study coordinator: Jeffrey N Weiss, MD
- Email: jweissmd@me.com
- Phone: 954-608-7604
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Doll Therapy for Apathy and Daily Living in Older Adults with Dementia
This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.